Home » MERCK TIES UP WITH PATH
MERCK TIES UP WITH PATH
Global pharma giant Merck & Co., Inc. said on Thursday that it has tied-up with non-profit organisation PATH to conduct clinical studies of Merck's investigational rotavirus vaccine, Rotateq, in Asia and Africa. The clinical trial sites will be identified in the next six months, with a goal of starting at least one trial by the end of 2006, the company said in a release.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May